The regulatory roles of phosphatases in cancer
J Stebbing, LC Lit, H Zhang, RS Darrington, O Melaiu… - Oncogene, 2014 - nature.com
The relevance of potentially reversible post-translational modifications required for
controlling cellular processes in cancer is one of the most thriving arenas of cellular and …
controlling cellular processes in cancer is one of the most thriving arenas of cellular and …
Shp1 in solid cancers and their therapy
A Varone, D Spano, D Corda - Frontiers in Oncology, 2020 - frontiersin.org
Shp1 is a cytosolic tyrosine phosphatase that regulates a broad range of cellular functions
and targets, modulating the flow of information from the cell membrane to the nucleus. While …
and targets, modulating the flow of information from the cell membrane to the nucleus. While …
Cell synchronization by double thymidine block
G Chen, X Deng - Bio-protocol, 2018 - bio-protocol.org
Cell synchronization is widely used in studying mechanisms involves in regulation of cell
cycle progression. Through synchronization, cells at distinct cell cycle stage could be …
cycle progression. Through synchronization, cells at distinct cell cycle stage could be …
Predicting patient response with models trained on cell lines and patient-derived xenografts by nonlinear transfer learning
Preclinical models have been the workhorse of cancer research, producing massive
amounts of drug response data. Unfortunately, translating response biomarkers derived from …
amounts of drug response data. Unfortunately, translating response biomarkers derived from …
[HTML][HTML] Photobiomodulation: Cellular, molecular, and clinical aspects
MCP Felician, R Belotto, JP Tardivo, MS Baptista… - … of Photochemistry and …, 2023 - Elsevier
Photobiomodulation (PBM) is a noninvasive photonic-based therapy, capable of dealing
with immune-inflammatory, neurological, and musculoskeletal disorders, as well as healing …
with immune-inflammatory, neurological, and musculoskeletal disorders, as well as healing …
Protein tyrosine phosphatases: mechanisms in cancer
V Sivaganesh, V Sivaganesh, C Scanlon… - International journal of …, 2021 - mdpi.com
Protein tyrosine kinases, especially receptor tyrosine kinases, have dominated the cancer
therapeutics sphere as proteins that can be inhibited to selectively target cancer. However …
therapeutics sphere as proteins that can be inhibited to selectively target cancer. However …
Effects of low-level laser irradiation on mesenchymal stem cell proliferation: a microarray analysis
Y Wu, J Wang, D Gong, H Gu, S Hu, H Zhang - Lasers in medical science, 2012 - Springer
Increased proliferation after low-level laser irradiation (LLLI) has been well demonstrated in
many cell types including mesenchymal stem cells (MSCs), but the exact molecular …
many cell types including mesenchymal stem cells (MSCs), but the exact molecular …
The role of nuclear receptors in prostate cancer
M Shiota, N Fujimoto, E Kashiwagi, M Eto - Cells, 2019 - mdpi.com
The nuclear receptor (NR) superfamily consists of 48 members that are divided into seven
subfamilies. NRs are transcription factors that play an important role in a number of …
subfamilies. NRs are transcription factors that play an important role in a number of …
Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma
Sorafenib is the first approved targeted therapeutic reagent for hepatocellular carcinoma
(HCC). Here, we report that Src homology region 2 (SH2) domain-containing phosphatase 1 …
(HCC). Here, we report that Src homology region 2 (SH2) domain-containing phosphatase 1 …
Protein tyrosine phosphatases in cancer: friends and foes!
DP Labbé, S Hardy, ML Tremblay - Progress in molecular biology and …, 2012 - Elsevier
Tyrosine phosphorylation of proteins serves as an exquisite switch in controlling several key
oncogenic signaling pathways involved in cell proliferation, apoptosis, migration, and …
oncogenic signaling pathways involved in cell proliferation, apoptosis, migration, and …